- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16:21 | Johnson & Johnson starts Phase 3 trial for COVID-19 vaccine | ||
| 16:21 | 'Viral vector production demand will ultimately exceed the current global capacity' | ||
| 16:21 | Researchers explore naturally occurring viral vectors: 'Our study will change the trajectory of AAV-based gene therapies' | ||
| Di | Siolta Therapeutics raises $30m in series B investment round | ||
| Di | ALSA Ventures closes US$59m European biotech venture capital fund | ||
| Di | Higher income economies sign up to global Covid-19 vaccine initiative, but not US, China or Russia | ||
| Di | Samsung Biologics and AstraZeneca launch strategic manufacturing partnership | ||
| Mo | Sandoz working to overcome barriers to greater biosimilars uptake in US | ||
| Mo | Sanofi & GSK sign deal to supply EU with 300 million COVID-19 vaccine doses | ||
| Mo | Roche acquires biotech start-up Inflazome | ||
| Do | BioNTech acquires German manufacturing site to boost COVID-19 vaccine production | ||
| Do | Epilepsy gene therapy candidate moves closer to clinical study phase | ||
| Do | CPhI: cell and gene therapy capacity shortages on the horizon | ||
| Do | AstraZeneca unveils Phase III kidney treatment results | ||
| 16.09. | Germany grants BioNTech, CureVac $745m to advance Covid-19 vaccine work | ||
| 15.09. | Merck expands its HPAPI and ADC manufacturing capabilities, capacity | ||
| 15.09. | Valneva to create 'major UK vaccine facility' as part of UK COVID-19 vaccine deal | ||
| 15.09. | Vaxart's oral COVID-19 tablet vaccine to enter clinical trials | ||
| 15.09. | Thermo Fisher addresses the growing need for more flexible, scalable biologics development | ||
| 14.09. | Gilead buys Immunomedics in $21bn deal set to strengthen its cancer portfolio | ||
| 14.09. | Merck to acquire $1bn equity stake in Seattle Genetics; announces two oncology collaborations | ||
| 14.09. | Pfizer and BioNTech prepare to expand COVID-19 vaccine trial | ||
| 14.09. | Cytiva invests for global capacity expansion | ||
| 14.09. | AstraZeneca resumes COVID-19 vaccine trials in the UK; awaits regulators elsewhere | ||
| 11.09. | Delivering COVID-19 vaccines safely will be the 'mission of the century' for air cargo industry |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
